Cargando…
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim
BACKGROUND: The last few decades have seen the approval of many new treatment options for Relapsing-Remitting Multiple Sclerosis (RRMS), as well as advances in diagnostic methodology and criteria. These developments have greatly improved the available treatment options for today’s Relapsing-Remittin...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665027/ https://www.ncbi.nlm.nih.gov/pubmed/36380294 http://dx.doi.org/10.1186/s12911-022-02034-x |